Windtree Therapeutics Inc.

11/22/2021 | Press release | Archived content

Research Finds U.S. Cardiogenic Shock Patients Have High Hospital Inpatient Mortality and Long Length of Stay – Adding to Previously Reported Need for New Pharmacologic Innovation